Old Web
English
Sign In
Acemap
>
Paper
>
The Bruton’s tyrosine kinase inhibitor ibrutinib abrogates bispecific antibody‐mediated T‐cell cytotoxicity
The Bruton’s tyrosine kinase inhibitor ibrutinib abrogates bispecific antibody‐mediated T‐cell cytotoxicity
2020
Colin D. Godwin
Olivia M. Bates
Eliotte E. Garling
Mary E. Beddoe
George S. Laszlo
Roland B. Walter
Keywords:
Antibody
Cytotoxicity
Immunology
Cancer research
Bruton's tyrosine kinase inhibitor
Ibrutinib
T cell
Bruton's tyrosine kinase
Medicine
bispecific antibody
t cell cytotoxicity
Correction
Source
Cite
Save
Machine Reading By IdeaReader
15
References
2
Citations
NaN
KQI
[]